"New CLARITIN(R) Liqui-Gels(R) is the latest advancement for the 50 million Americans who suffer from allergies," said Dr. John O'Mullane, group vice president, research and development, Schering-Plough Consumer Health Care. "We are pleased to bring this innovative form to the line of non-drowsy CLARITIN(R) products." Liquid-filled capsules are extremely popular with consumers. A recent survey* found that 75 percent of consumers who use liquid-filled capsules prefer them over tablets.
Like all CLARITIN(R) products, new CLARITIN(R) Liqui-Gels(R) are available without a prescription and treat allergy symptoms such as itchy, watery eyes, sneezing and runny nose without drowsiness. CLARITIN(R) Liqui-Gels(R) are approved for adults and children ages 6 and older and can be found wherever over-the-counter products are sold.
All CLARITIN(R) brand products are available without a prescription, including: CLARITIN(R) Tablets, a once-daily, full prescription strength, non-drowsy formulation; CLARITIN(R) RediTabs(R) Tablets, a novel once-daily formulation in a quickly dissolving tablet for ages 6 and older; CLARITIN(R) Liqui-Gels(R), a once-daily formulation in an easy-to-swallow liquid-filled capsule; CLARITIN-D(R) 24-hour and 12-hour Extended Release Tablets, with the decongestant pseudoephedrine, now located behind the counter; CHILDREN'S CLARITIN(R) Syrup, a liquid formulation for children ages 2 and older in grape and fruit flavors; and CHILDREN'S CLARITIN(R) Grape Chewables, a chewable tablet for children ages 2 and older.
CLARITIN(R) is the No. 1 physician-recommended and pediatrician-recommended non-drowsy over-the-counter allergy brand. The CLARITIN(R) Rx-to-OTC switch in 2002 was the largest switch ever--and the first and only for a non-drowsy antihistamine. For more information on allergies and treatment, visit www.CLARITIN.com.
Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.